fda compounding semaglutide warning letters october 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our Beyond the Headlines: FDA Warning

12 PEPTIDES TO HELP IMPROVE THE LOOK OF SKIN TEXTURE: Features a blend of 12 peptides, including GHK-Cu, Acetyl Hexapeptide-8, and Palmitoyl Pentapeptide-4

Supporting these pathways helps create a more proactive approach to long-term skin, recovery, and longevity-focused wellness

Changes in Bowel Habits : Changes in bowel habits like diarrhea and constipation

The product is based on a combination of effective ingredients such as Myo-Inositol, D-Chiro Inositol, L-Carnitine, along with essential vitamins, minerals, folic acid , and selenium, all of which are known for their role in supporting reproductive health and hormonal balance

I am five pounds from goal and have been for years